Filtros de búsqueda

Lista de obras de Maria Elisa Mancuso

Common themes and challenges in hemophilia care: a multinational perspective

artículo científico publicado en 2018

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A ⬇️

artículo científico publicado el 14 de marzo de 2011

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-half-life FVIII to BAY 94-9207 Prophylaxis

scientific article published on 09 December 2020

Emicizumab for hemophilia A without inhibitors

artículo científico publicado en 2019

High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study

artículo científico publicado en 2019

ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study

artículo científico publicado en 2020

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.

artículo científico publicado en 2017

Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates.

artículo científico publicado en 2017

Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms

artículo científico publicado en 2020

Platelets: much more than bricks in a breached wall.

artículo científico publicado en 2017

Prospective hemophilia inhibitor PUP study reveals distinct antibody signatures during FVIII inhibitor eradication

artículo científico publicado en 2022

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors ⬇️

artículo científico publicado el 15 de febrero de 2011

Switching patients in the age of long-acting recombinant products?

scientific article published on 01 January 2019

Target joint resolution in patients with haemophilia A receiving long-term prophylaxis with BAY 94-9027

artículo científico publicado en 2020

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda